Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$24.14 - $30.37 $4.81 Million - $6.05 Million
199,264 New
199,264 $5.33 Million
Q3 2021

Nov 12, 2021

SELL
$53.61 - $67.5 $16.3 Million - $20.5 Million
-304,410 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$45.13 - $64.99 $9.72 Million - $14 Million
215,363 Added 241.85%
304,410 $17.5 Million
Q1 2021

May 14, 2021

SELL
$29.77 - $84.85 $861,037 - $2.45 Million
-28,923 Reduced 24.52%
89,047 $5.64 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $371,608 - $500,353
14,482 Added 13.99%
117,970 $3.96 Million
Q3 2020

Nov 13, 2020

BUY
$22.51 - $30.11 $2.33 Million - $3.12 Million
103,488 New
103,488 $2.83 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.